Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression

Clin Nephrol. 1997 Nov;48(5):269-73.

Abstract

Clinical observations: Three patients with previous pulmonary infections were recently admitted with rapidly progressive renal failure. Renal biopsy showed crescentic glomerulonephritis with deposits of IgA, C3c and C3d. Serology disclosed P-ANCA with high-titer anti-myeloperoxidase antibodies. Two out of three patients became dialysis dependent despite immunosuppression with methylprednisolone and cyclophosphamide. Renal function improved in both patients after 2 weeks and 9 months, respectively, permitting termination of hemodialysis. All patients benefited from immunosuppressive treatment which is currently still being continued.

Conclusion: The data suggest that early immunosuppression is beneficial in patients presenting with crescentic rapidly progressive IgA GN and anti-myeloperoxidase antibodies, which may represent a novel subset of crescentic IgA GN associated with high-titer anti-myeloperoxidase antibodies constituting an overlap group between microscopic polyangiitis and IgA GN.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Antineutrophil Cytoplasmic / blood
  • Autoantibodies / blood
  • Biopsy
  • Disease Progression
  • Female
  • Glomerulonephritis, IGA / drug therapy*
  • Glomerulonephritis, IGA / immunology*
  • Glomerulonephritis, IGA / pathology
  • Humans
  • Immunohistochemistry
  • Immunosuppressive Agents / therapeutic use*
  • Kidney / pathology
  • Male
  • Middle Aged
  • Peroxidase / immunology*

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Autoantibodies
  • Immunosuppressive Agents
  • Peroxidase